Xenetic Biosciences Inc.

(NASDAQ: XBIO) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer.

Contact Information

Website: www.xeneticbio.com
Email: jtc@jenenethomascommunications.com
Main Phone: +1 781 778-7720
Address: 40 Speen Street
Address 2: Suite 102
State: MA
City / Town: Framingham
Country: US
Postal Code: 01701

Issuer Information

Exchange: NSC
CEO: Jeffrey F. Eisenberg
Employees: 4
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A